TherapeuticsMD Inc. (TXMD)
NASDAQ: TXMD
· Real-Time Price · USD
1.17
0.02 (1.72%)
At close: Aug 15, 2025, 3:58 PM
1.18
0.86%
After-hours: Aug 15, 2025, 07:44 PM EDT
TherapeuticsMD Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.56M | 1.84M | 1.76M | 1.6M | 996K | 1.2M | 1.3M | 1.95M | 22.92M | 51.05M | 69.96M | 87.49M | 91.98M | 86.42M | 86.95M | 90.85M | 84.79M | 72.49M |
Cost of Revenue | 229K | 133K | 266K | 770K | 900K | 1.03M | 922K | 3.72M | 7.38M | 11.99M | 16.82M | 18.13M | 19.62M | 19.01M | 18.84M | 19.68M | 17.68M | 17.95M |
Gross Profit | 2.36M | 1.74M | 1.53M | 826K | 96K | 171K | 380K | -1.77M | 15.54M | 39.06M | 53.14M | 69.36M | 72.36M | 67.41M | 68.11M | 71.17M | 67.11M | 54.54M |
Operating Income | -2.74M | -4.49M | -4.76M | -6.05M | -6.97M | -7M | -8.52M | 104.67M | 85.69M | 69.32M | 45.76M | -101.21M | -120.38M | -136.72M | -139.77M | -138.98M | -124.04M | -133.9M |
Interest Income | n/a | n/a | n/a | 300K | 300K | 300K | 300K | n/a | 4.83M | 4.83M | 4.83M | 4.83M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -607K | -2.2M | -2.34M | -4.01M | -4.88M | -6.24M | -7.74M | -39.67M | -67.46M | 47.78M | 1.07M | -8.38M | -26.57M | -182.05M | -172.41M | -171.54M | -156.73M | -166.06M |
Net Income | -459K | -2.1M | -2.18M | -3.32M | -6.08M | -7.41M | -10.28M | -42.62M | -68.2M | 46.49M | -21.72M | -31.46M | -49.91M | -204.84M | -172.41M | -171.54M | -156.73M | -166.06M |
Selling & General & Admin | 4.82M | 4.5M | 4.74M | 5.34M | 5.62M | 7.17M | 8.9M | -51.82M | -16.64M | 21.66M | 57.9M | 165.06M | 186.74M | 197.69M | 200.8M | 201.83M | 182.14M | 178.44M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.09M | -2.98M | -1.4M | n/a | 5.51M | 6M | 6.44M | 7.09M | 8.06M | 8.48M | 9.21M |
Other Expenses | 482K | 1.83M | 1.64M | 1.54M | 1.8M | 462K | 489K | 3.96M | 3.6M | 3.48M | 3.45M | -8K | 11K | 150K | 272K | 395.9K | 418.31K | 384.17K |
Operating Expenses | 5.2M | 6.22M | 6.28M | 6.88M | 7.19M | 7.43M | 9.19M | -55.63M | -19.47M | 20.28M | 57.9M | 170.57M | 192.74M | 204.13M | 207.88M | 210.15M | 191.15M | 188.44M |
Interest Expense | 7K | 10K | 8K | 93K | 110K | 150K | 200K | 34.28M | 36.51M | 40.24M | 45.55M | 18.96M | 22.75M | 26.58M | 31.44M | 31.48M | 33.12M | 32.55M |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.58M | -1.58M | -1.58M | -1.58M | -61.7M | -42.57M | -18.89M | n/a | 83.7M | 94.58M | 103.07M | 108.19M | -57.83M | -65.46M | -67.73M |
Cost & Expenses | 5.3M | 6.33M | 6.52M | 7.65M | 7.96M | 8.2M | 9.82M | -67.62M | -27.67M | 16.82M | 59.3M | 188.7M | 212.36M | 223.14M | 226.72M | 229.84M | 208.82M | 206.38M |
Income Tax Expense | -69K | -63K | -31K | -43K | -43K | -43K | -43K | -290K | -550K | n/a | 22.79M | 23.08M | 23.34M | 22.79M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 11.57M | 11.55M | 11.53M | 11.53M | 11.53M | 11.53M | 11.53M | 10.7M | 10.22M | 9.75M | 9.37M | 9.25M | 8.75M | 8.59M | 8.55M | 8.44M | 7.88M | 6.94M |
Shares Outstanding (Diluted) | 11.57M | 11.55M | 11.53M | 11.53M | 11.53M | 11.53M | 11.53M | 10.7M | 10.22M | 9.75M | 9.37M | 9.26M | 9.06M | 8.61M | 8.55M | 8.44M | 7.88M | 6.95M |
EPS (Basic) | -0.04 | -0.18 | -0.19 | -0.29 | -0.55 | -0.7 | -1.01 | -4.48 | -7.29 | 5.78 | -2.21 | -3.69 | -6.18 | -24.42 | -21.73 | -24.25 | -24.63 | -28.78 |
EPS (Diluted) | -0.04 | -0.18 | -0.19 | -0.29 | -0.55 | -0.7 | -1.01 | -4.48 | -7.29 | 5.34 | -2.63 | -4.11 | -6.6 | -24.4 | -21.73 | -24.04 | -24.4 | -28.55 |
EBITDA | -1.38M | -2.88M | -2.99M | -2.88M | -3.69M | -5.06M | -6.62M | 103.83M | 84.37M | 72.03M | 56.72M | -87.25M | -106.42M | -127.03M | -138.76M | -137.47M | -122.01M | -131.35M |
EBIT | -1.76M | -3.35M | -3.5M | -3.92M | -4.77M | -6.09M | -7.54M | -40.85M | -60.37M | -72.86M | -88.48M | -89.05M | -109.5M | -131.1M | -143.66M | -142.75M | -126.3M | -134.78M |
Depreciation & Amortization | 387K | 471K | 509K | 1.05M | 1.08M | 1.03M | 922K | -1.7M | -798K | 120K | 1.19M | 4.18M | 4.18M | 4.46M | 4.59M | 4.97M | 4.96M | 3.89M |